What is he best known for?
The fields of study he is best known for:
- Immune system
- Cytokine
- Inflammation
His main research concerns Immunology, Immune system, CXCR3, Receptor and Chemokine receptor.
His Immunology research is multidisciplinary, relying on both Cytotoxic T cell and Lung injury.
In his study, Tuberculosis, Granuloma and Mycobacterium tuberculosis is inextricably linked to Lung, which falls within the broad field of Immune system.
His CXCR3 research includes elements of CXCL10 and CXCL9.
He studied CXCL9 and Lymphatic system that intersect with Cell biology.
His work deals with themes such as Intestinal mucosa, Caco-2, Molecular biology, Zonulin and C5a receptor, which intersect with Receptor.
His most cited work include:
- Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice (952 citations)
- Metabolic Regulation of Brain Aβ by Neprilysin (784 citations)
- Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection (588 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Immunology, CXCR3, Receptor, Chemokine and Inflammation.
His study connects Cytotoxic T cell and Immunology.
His CXCR3 study also includes
- Lung injury most often made with reference to CXCL10,
- Molecular biology, which have a strong connection to Lymphocyte.
His biological study spans a wide range of topics, including C5a receptor, Anaphylatoxin, Tumor necrosis factor alpha and Cell biology.
His study in Proinflammatory cytokine extends to Chemokine with its themes.
His study on Inflammation also encompasses disciplines like
- Substance P and related Neprilysin,
- Knockout mouse most often made with reference to Endocrinology.
He most often published in these fields:
- Immunology (66.15%)
- CXCR3 (36.15%)
- Receptor (23.85%)
What were the highlights of his more recent work (between 2011-2019)?
- Immunology (66.15%)
- Virology (9.23%)
- CXCR3 (36.15%)
In recent papers he was focusing on the following fields of study:
Bao Lu mainly focuses on Immunology, Virology, CXCR3, Receptor and Inflammation.
His Immunology study incorporates themes from Signal transduction and Phosphoinositide 3-kinase.
The study incorporates disciplines such as Myofibroblast, CXCL10, Ventricular remodeling, Cell biology and Cardiac fibrosis in addition to CXCR3.
His work in the fields of CXCL9 overlaps with other areas such as MDA5.
His Receptor research is multidisciplinary, incorporating elements of Complement system, Pathophysiology, Edema and Nasal administration.
His Inflammation research includes themes of Inoculation and C3a receptor.
Between 2011 and 2019, his most popular works were:
- CXCL10-CXCR3 Enhances the Development of Neutrophil-mediated Fulminant Lung Injury of Viral and Nonviral Origin (158 citations)
- C3a and C5a Promote Renal Ischemia-Reperfusion Injury (129 citations)
- Brain Endothelial- and Epithelial-Specific Interferon Receptor Chain 1 Drives Virus-Induced Sickness Behavior and Cognitive Impairment. (81 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Cytokine
- Inflammation
His scientific interests lie mostly in Immunology, CXCL10, CXCR3, Pathogenesis and Cutaneous leishmaniasis.
The concepts of his Immunology study are interwoven with issues in Fibroblast migration, Ventricular remodeling, Cell biology, Lung injury and Cardiac fibrosis.
He has included themes like RIG-I, Mitochondrial antiviral-signaling protein, Signal transduction, Interferon type I and Sickness behavior in his CXCL10 study.
His CXCR3 study combines topics in areas such as Virus, Influenza A virus, Virology and ARDS.
He has researched Pathogenesis in several fields, including Receptor, Kidney and Cellular infiltration.
His study in Cutaneous leishmaniasis is interdisciplinary in nature, drawing from both Phagocytosis and Phosphoinositide 3-kinase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
